Catarina Lopes Selected Research

Hydroxyprostaglandin Dehydrogenases (Hydroxyprostaglandin Dehydrogenase)

1/2021

Genetic Variations in Prostaglandin E2 Pathway Identified as Susceptibility Biomarkers for Gastric Cancer in an Intermediate Risk European Country.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catarina Lopes Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 10/2020
2	Inflammation (Inflammations) 01/2021 - 10/2020
1	Neuralgia (Stump Neuralgia) 01/2022
1	Carcinogenesis 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Adenocarcinoma 10/2020

Drug/Important Bio-Agent (IBA)

2	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2020
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 10/2020
2	Organic Anion TransportersIBA 01/2021 - 10/2020
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 10/2020
2	Dinoprostone (PGE2)FDA Link 01/2021 - 10/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	Hydroxyprostaglandin Dehydrogenases (Hydroxyprostaglandin Dehydrogenase)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2021
1	15-hydroxyprostaglandin dehydrogenaseIBA 10/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020

Therapy/Procedure

1	Mastectomy (Mammectomy) 01/2022
1	Therapeutics 01/2021